A recent study has found at Clostridioides difficile (C. diff) comes with costs, as well as increased hospital stays, when the infection is acquired in the hospital, according to an article on the MD website.
In the study, investigators examined adult patients both with hospital-acquired C. Diff and without between April 1, 2012 and March 31, 2016.
The team estimated the cost of C. diff to be about $5.4 billion in the US, $4.7 billion of which was incurred in healthcare settings, mostly due to hospitalizations and recurrence.
The average healthcare cost for patients with the C. diff infection was $43,718 compared to $19,513 for those patients without.
Why Cyber Readiness Is the New Standard of Care
Smarter, Faster, Safer: The Rise of AI in Healthcare Security Technologies
The WHO and UNICEF Release New Global Hand Hygiene Guidelines
Swatting Calls, Hoax Threats Have Real Consequences for Healthcare
Next Level Announces Expansion of Conroe, Texas Clinic